Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease

Mental Health Research Institute, The University of Melbourne, Parkville, Victoria 3052, Australia.
Cell (Impact Factor: 32.24). 09/2010; 142(6):857-67. DOI: 10.1016/j.cell.2010.08.014
Source: PubMed


Alzheimer's Disease (AD) is complicated by pro-oxidant intraneuronal Fe(2+) elevation as well as extracellular Zn(2+) accumulation within amyloid plaque. We found that the AD β-amyloid protein precursor (APP) possesses ferroxidase activity mediated by a conserved H-ferritin-like active site, which is inhibited specifically by Zn(2+). Like ceruloplasmin, APP catalytically oxidizes Fe(2+), loads Fe(3+) into transferrin, and has a major interaction with ferroportin in HEK293T cells (that lack ceruloplasmin) and in human cortical tissue. Ablation of APP in HEK293T cells and primary neurons induces marked iron retention, whereas increasing APP695 promotes iron export. Unlike normal mice, APP(-/-) mice are vulnerable to dietary iron exposure, which causes Fe(2+) accumulation and oxidative stress in cortical neurons. Paralleling iron accumulation, APP ferroxidase activity in AD postmortem neocortex is inhibited by endogenous Zn(2+), which we demonstrate can originate from Zn(2+)-laden amyloid aggregates and correlates with Aβ burden. Abnormal exchange of cortical zinc may link amyloid pathology with neuronal iron accumulation in AD.

Download full-text


Available from: Ashley I Bush
  • Source
    • "Linked reports also confirmed that amyloid-␤ protein precursor (A␤PP) mRNA has an iron-responsive element RNA stem loop in its 5'-UTR and the translation of A␤PP is under the regulation of iron [17] [18]. One key 2010 study suggested that A␤PP protein, in excess, can control iron export from neurons in the brain [19]. These papers lent support to the earlier genetic reports that linked mutations of iron-related genes, including transferrin , with the risk of AD, thus suggesting that iron mis-management could contribute to the initiation and progression of brain disorders [20] [21] [22] [23]. "

    Full-text · Dataset · May 2015
  • Source
    • "For example, increased levels of the iron importer DMT1 has been observed in the cortex and hippocampus of AD transgenic models (Zheng et al., 2009), whereas levels of the iron storage protein ferritin are increased in reactive microglia present both in and around senile plaques (Connor et al., 1992). Similarly, AD brains show decreased levels of the iron exporter ferroportin 1 (Fpn1) (Crespo et al., 2014; Raha et al., 2013) and ferroxidase activity of APP (Duce et al., 2010) together with reduced levels of ceruloplasmin (Connor et al., 1993), which are required for the release of iron from cells. All these changes in iron homeostasis proteins clearly point to an iron accumulation phenotype, with an evident risk for the development of metal-based neurodegeneration. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Synthesis of the iron-containing prosthetic groups-heme and iron-sulfur clusters-occurs in mitochondria. The mitochondrion is also an important producer of reactive oxygen species (ROS), which are derived from electrons leaking from the electron transport chain. The coexistence of both ROS and iron in the secluded space of the mitochondrion makes this organelle particularly prone to oxidative damage. Here, we review the elements that configure mitochondrial iron homeostasis and discuss the principles of iron-mediated ROS generation in mitochondria. We also review the evidence for mitochondrial dysfunction and iron accumulation in Alzheimer's disease, Huntington Disease, Friedreich's ataxia, and in particular Parkinson's disease. We postulate that a positive feedback loop of mitochondrial dysfunction, iron accumulation, and ROS production accounts for the process of cell death in various neurodegenerative diseases in which these features are present. Copyright © 2015. Published by Elsevier B.V.
    Full-text · Article · Feb 2015 · Mitochondrion
  • Source
    • "It has two homologues, APLP-1 and APLP-2. APP has been linked to a variety of cellular functions, including iron transport and homeostasis (Duce et al., 2010). Among other functions, the APP C-terminal domain (AICD) seems to affect transcription alongside cofactor Fe65, after its recruitment to membrane-bound APP. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We recently reported that Amyloid Precursor Protein (APP) regulates global protein synthesis in a variety of human dividing cells, including non-small cell lung cancer (NSCLC) cells. More specifically, APP depletion causes an increase of both cap- and IRES-dependent translation. Since growth and proliferation are tightly coupled processes, here we asked what effects artificial downregulation of APP could have elicited in NSCLC cells proliferation. APP depletion caused a G0/G1 arrest through destabilization of the cyclin-C protein and reduced pRb phosphorylation at residues Ser802/811. siRNA to cyclin-C mirrored the cell cycle distribution observed when silencing APP. Cells arrested in G0/G1 (and with augmented global protein synthesis) increased their size and underwent a necrotic cell death due to cell membrane permeabilization. These phenotypes were reversed by overexpression of the APP C-terminal domain, indicating a novel role for APP in regulating early cell cycle entry decisions. It is seems that APP moderates the rate of protein synthesis before the cell clears growth factors-and nutrients-dependent checkpoint in mid G1. Our results raise questions on how such processes interact in the context of (at least) dividing NSCLC cells. The data presented here suggest that APP, although required for G0/G1 transitions, moderates the rate of protein synthesis before the cell fully commits to cell cycle progression following mechanisms, which seem additional to concurrent signals deriving from the PI3-K/Akt/mTORC-1 axis. APP appears to play a central role in regulating cell cycle entry with the rate of protein synthesis; and its loss-of-function causes cell size abnormalities and death. This article is protected by copyright. All rights reserved
    Full-text · Article · Dec 2014 · Journal of Cellular Physiology
Show more